SCCA Immunotherapy

car-tcell-therapy-faq


Seattle Cancer Care Alliance (SCCA) is one of the first cancer centers in the nation to offer both FDA-approved CAR T-cell therapies. Tisagenlecleucel, known by the brand name Kymriah®, and axicabtagene ciloleucel (axi-cel), known by the brand name Yescarta®, are available only at certified treatment centers such as SCCA. This type of immunotherapy uses engineered T cells to harness the power of a patient’s own immune system to treat certain types of non-Hodgkin lymphoma (NHL) and acute lymphoblastic leukemia (ALL).

CAR T-cell Therapies